Table 1 Characteristics of the mouse... | American Society of Hematology

Table 1

Characteristics of the mouse cohorts

Donor	Population	Treatment	Recipient	Hematopoietic tumors
Donor	Population	Treatment	Recipient	%	B-cell	T-cell
AR
n = 19	—	—	—	26	5/19	0/19
n = 11	Sca1⁺	Mock	WT	100	10/11	1/11
n = 12	Sca1⁺	GFP	WT	100	10/12	2/12
n = 10	Sca1⁺CD19⁻	GFP	WT	60	4/10	2/10
n = 8	Sca1⁺CD19⁻	Rag1	WT	88	2/8	5/8
A
n = 17	—	—	—	17	0/17	3/17
n = 9	Sca1⁺	Mock	WT	11	0/9	1/9
n = 9	Sca1⁺	GFP	WT	22	0/9	2/9

Donor	Population	Treatment	Recipient	Hematopoietic tumors
Donor	Population	Treatment	Recipient	%	B-cell	T-cell
AR
n = 19	—	—	—	26	5/19	0/19
n = 11	Sca1⁺	Mock	WT	100	10/11	1/11
n = 12	Sca1⁺	GFP	WT	100	10/12	2/12
n = 10	Sca1⁺CD19⁻	GFP	WT	60	4/10	2/10
n = 8	Sca1⁺CD19⁻	Rag1	WT	88	2/8	5/8
A
n = 17	—	—	—	17	0/17	3/17
n = 9	Sca1⁺	Mock	WT	11	0/9	1/9
n = 9	Sca1⁺	GFP	WT	22	0/9	2/9

Numbers of mice are indicated for each group used in this study, along with the donor population, ex vivo treatments, the percentage of animals having developed hematopoietic tumors, and the tumor phenotype.

AR indicates p19Arf^−/−Rag1^−/−; A, p19Arf^−/−; —, not applicable; WT, wild type; and GFP, green fluorescent protein.

View Large

This Feature Is Available To Subscribers Only